BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20021704)

  • 21. Short chain fatty acids in inflammatory bowel disease. The effect of bacterial fermentation of blood.
    Holtug K; Rasmussen HS; Mortensen PB
    Scand J Clin Lab Invest; 1988 Nov; 48(7):667-71. PubMed ID: 3201099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of source and concentrations of dietary fiber on in vivo nitrogen excretion pathways in pigs as reflected by in vitro fermentation and nitrogen incorporation by fecal bacteria.
    Bindelle J; Buldgen A; Delacollette M; Wavreille J; Agneessens R; Destain JP; Leterme P
    J Anim Sci; 2009 Feb; 87(2):583-93. PubMed ID: 18791157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
    Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
    Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet.
    Khalil NA; Walton GE; Gibson GR; Tuohy KM; Andrews SC
    Int J Food Sci Nutr; 2014 Feb; 65(1):79-88. PubMed ID: 23941288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics.
    Bird AR; Conlon MA; Christophersen CT; Topping DL
    Benef Microbes; 2010 Nov; 1(4):423-31. PubMed ID: 21831780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats.
    Le Leu RK; Brown IL; Hu Y; Morita T; Esterman A; Young GP
    Carcinogenesis; 2007 Feb; 28(2):240-5. PubMed ID: 17166881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal fibre usage in UC in remission.
    James SL; Christophersen CT; Bird AR; Conlon MA; Rosella O; Gibson PR; Muir JG
    Gut; 2015 Apr; 64(4):562-70. PubMed ID: 25037189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dietary fiber on inflammatory bowel disease.
    Galvez J; Rodríguez-Cabezas ME; Zarzuelo A
    Mol Nutr Food Res; 2005 Jun; 49(6):601-8. PubMed ID: 15841496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
    Duboc H; Rajca S; Rainteau D; Benarous D; Maubert MA; Quervain E; Thomas G; Barbu V; Humbert L; Despras G; Bridonneau C; Dumetz F; Grill JP; Masliah J; Beaugerie L; Cosnes J; Chazouillères O; Poupon R; Wolf C; Mallet JM; Langella P; Trugnan G; Sokol H; Seksik P
    Gut; 2013 Apr; 62(4):531-9. PubMed ID: 22993202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
    Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
    Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Starch fermentation by faecal bacteria of infants, toddlers and adults: importance for energy salvage.
    Christian MT; Edwards CA; Preston T; Johnston L; Varley R; Weaver LT
    Eur J Clin Nutr; 2003 Nov; 57(11):1486-91. PubMed ID: 14576763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary carbohydrate source influences molecular fingerprints of the rat faecal microbiota.
    Licht TR; Hansen M; Poulsen M; Dragsted LO
    BMC Microbiol; 2006 Nov; 6():98. PubMed ID: 17137493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring non-steady-state metabolic fluxes in starch-converting faecal microbiota in vitro.
    Binsl TW; De Graaf AA; Venema K; Heringa J; Maathuis A; De Waard P; Van Beek JH
    Benef Microbes; 2010 Nov; 1(4):391-405. PubMed ID: 21831778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease.
    Marchesi JR; Holmes E; Khan F; Kochhar S; Scanlan P; Shanahan F; Wilson ID; Wang Y
    J Proteome Res; 2007 Feb; 6(2):546-51. PubMed ID: 17269711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fermentation of resistant starches: influence of in vitro models on colon carcinogenesis.
    Fässler C; Gill CI; Arrigoni E; Rowland I; Amadò R
    Nutr Cancer; 2007; 58(1):85-92. PubMed ID: 17571971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical Inaccessibility of a Resistant Starch Shifts Mouse Gut Microbiota to Butyrogenic Firmicutes.
    Kaur A; Chen T; Green SJ; Mutlu E; Martin BR; Rumpagaporn P; Patterson JA; Keshavarzian A; Hamaker BR
    Mol Nutr Food Res; 2019 Apr; 63(7):e1801012. PubMed ID: 30659764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.